S 778 – Massachusetts

Status: In Process
Year Introduced: 2023
Link: https://malegislature.gov/Bills/193/S778

An Act to bring down the cost of prescription drugs. Notwithstanding any general or special law to the contrary, the health policy commission shall conduct a study examining the feasibility of establishing a program for the commonwealth to direct the manufacture of generic or biosimilar prescription drugs.

Return to Database Search

© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found